Journal of Veterinary Medicine and Health
Open Access

Antimicrobial resistance (AMR) is one of the most pressing global health challenges of the 21st century. It occurs when microorganisms such as bacteria, fungi, viruses, and parasites evolve to resist the drugs that once killed or inhibited them. This resistance can make infections harder to treat, leading to longer hospital stays, increased healthcare costs, and a greater risk of mortality [1]. As the overuse and misuse of antibiotics and other antimicrobial agents continue, the spread of AMR poses a severe threat to public health worldwide. Without effective measures to combat this issue, previously treatable infections could once again become fatal.

What is Antimicrobial Resistance

Antimicrobial resistance refers to the ability of microbes to survive or grow despite being exposed to drugs that would normally kill them or inhibit their growth. The most commonly discussed form of AMR involves bacteria that resist antibiotics, but the problem extends to other pathogens, including viruses, fungi, and parasites. Resistance occurs naturally over time through genetic mutations, but the process is accelerated by human activities [2]. The overprescription of antibiotics, inappropriate use in agriculture, poor infection prevention and control, and inadequate sanitation all contribute to the emergence and spread of resistant organisms.

The Mechanisms of Resistance

Microorganisms can become resistant to antimicrobials through several mechanisms:

Genetic mutation: Spontaneous mutations in the microbe’s DNA can lead to resistance. These mutations may affect the drug target sites or enzymes that the antimicrobial drug targets, rendering it ineffective.

Gene transfer: Bacteria can exchange resistance genes with one another through horizontal gene transfer. This process allows resistant bacteria to spread their resistance to others [3], including strains that were once susceptible to treatment.

Efflux pumps: Some bacteria have developed efflux pumps, which actively expel antibiotics from the cell, preventing the drug from reaching its target.

Enzymatic inactivation: Some microbes produce enzymes, such as beta-lactamases, which break down or modify the antimicrobial drug, rendering it ineffective.

Factors Driving Antimicrobial Resistance

Several factors contribute to the growing problem of AMR:

Overuse and misuse of antibiotics: Antibiotics are often prescribed unnecessarily for viral infections, where they are ineffective [4], or for conditions that resolve on their own, like mild respiratory infections. This overuse promotes resistance by allowing bacteria to develop mechanisms to survive drug treatment.

Inappropriate use in agriculture: In many countries, antibiotics are used in livestock to promote growth or prevent disease, even in healthy animals. This practice accelerates the development of resistance in both animals and humans through the food supply.

Poor infection control in healthcare settings: Inadequate hygiene, improper sterilization of medical equipment, and insufficient infection control protocols in hospitals can foster the spread of resistant bacteria.

Self-medication: In some parts of the world [5], individuals self-medicate with antibiotics without proper guidance, often taking incorrect doses or using antibiotics for the wrong conditions, further contributing to resistance.

Global travel and trade: Resistant microbes can spread rapidly across borders due to international travel and trade. What may begin as a localized issue in one country can quickly become a global concern.

Consequences of Antimicrobial Resistance

The implications of AMR are vast and concerning. If resistance continues to increase, common infections such as urinary tract infections, pneumonia, and tuberculosis could become harder to treat. Infections from surgery, cancer treatment, and organ transplants also rely on effective antibiotics to prevent complications, and without these drugs, medical procedures would become far more dangerous. AMR could also lead to longer hospital stays and more complicated treatments, as patients require stronger, more expensive, and more toxic drugs. Additionally, the spread of resistant infections could overwhelm healthcare systems, especially in low-income countries with limited access to healthcare resources.

Global Efforts to Combat AMR

Recognizing the urgent nature of AMR, governments, international organizations, and healthcare agencies have launched initiatives to address the crisis. The World Health Organization (WHO) has been at the forefront of the global effort, advocating for a One Health approach, which considers human, animal, and environmental health together. Key strategies include:

Raising awareness: Public education campaigns aim to increase understanding of AMR and promote responsible use of antibiotics. This includes informing both healthcare professionals and the public about when and how antibiotics should be used.

Improved stewardship: Antimicrobial stewardship programs encourage healthcare providers to prescribe antibiotics only when necessary, at the right dose, and for the appropriate duration. This reduces the chances of resistance developing.

Infection prevention and control: Strengthening infection control measures in healthcare settings, improving sanitation and hygiene, and encouraging vaccinations can reduce the need for antibiotics and prevent the spread of resistant bacteria.

Surveillance and monitoring: Enhanced surveillance of AMR helps track trends in resistance, identify emerging threats, and guide public health responses. Regular monitoring of antibiotic use in both humans and animals also helps curb misuse.

Research and development: There is a critical need for the development of new antibiotics, vaccines, and diagnostic tools to combat resistant infections. However, research in this field has slowed, partly due to financial challenges and the lengthy process required to bring new drugs to market.

Regulation of antibiotics in agriculture: Many countries have implemented or are working toward regulating the use of antibiotics in agriculture, particularly in the absence of disease, to curb resistance. This includes limiting the use of antibiotics as growth promoters in animals.

The Role of the Public in Combating AMR

The public also plays a vital role in tackling AMR. Individuals can contribute by:

Taking antibiotics as prescribed: Patients should always follow healthcare providers’ instructions, including completing the full course of antibiotics even if they feel better. This ensures that all the bacteria are killed and prevents the survival of resistant strains.

Avoiding self-medication: People should not take antibiotics without a prescription or use leftover antibiotics from a previous illness.

Practicing good hygiene: Simple actions like frequent handwashing and proper food handling can reduce the need for antibiotics by preventing infections from spreading.

Vaccination: Getting vaccinated against preventable diseases, like influenza and pneumonia, reduces the likelihood of infections that require antibiotic treatment.

Conclusion

Antimicrobial resistance is an urgent global issue that threatens the effectiveness of many life-saving treatments. While the challenge is significant, there are ongoing efforts to slow the development of resistance and promote responsible use of antimicrobial agents. Governments, healthcare providers, and the public must all work together to reduce the misuse of antibiotics, enhance infection prevention strategies, and foster research into new treatments. Only through a collective effort can we ensure that antibiotics remain a vital tool for protecting public health in the years to come.

References

1. Granstrom DE (2003) Agricultural (nonbiomedical) animal research outside the laboratory: a review of guidelines for institutional animal care and use committees. ILAR J 44:206-10.

Indexed at, Crossref, Google Scholar

2. Nuttall TJ, Marsella R, Rosenbaum MR, Gonzales AJ, Fadok VA, et al. ( 2019) Update on pathogenesis, diagnosis, and treatment of atopic dermatitis in dogs. J Am Vet Med Assoc 254:1291-1300.

Indexed at, Crossref, Google Scholar

3. Domenico Santoro (2019) Therapies in canine atopic dermatitis: an update. Vet Clin North Am Small Anim Pract 49:9-26.

Indexed at, Crossref, Google Scholar

4. Dereje T, Mengistu U, Getachew A, Yoseph M (2015) A review of productive and reproductive characteristics of indigenous goats in Ethiopia.Livestock Research for Rural Development27:2015.

Google Scholar

5. Rathore KS, Pandeya D, Campbell LM, Wedegaertner TC, Puckhaber L, et al. (2020) Ultra-low gossypol cottonseed: Selective gene silencing opens up a vast resource of plant-based protein to improve human nutrition.Critical Reviews in Plant Sciences39: 1-29.

Google Scholar, Crossref